The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trends in Brazilian oncology studies over the last 5 ASCO Annual Meetings and their representation of Brazilian Oncology Census data.
 
Gustavo Bretas
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Novartis; Roche
Travel, Accommodations, Expenses - Lilly; United Medical
 
Aline Goncalves
Consulting or Advisory Role - Lilly; Novartis; Novartis; Pfizer; United Medical
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Lilly; Novartis; Pfizer
 
Clarissa Baldotto
Honoraria - AstraZeneca; BMS Brazil; Janssen Oncology Brazil; MD Health; MSD Oncology Brazil; Pfizer Oncology Brazil; Roche Oncology Brazil; Servier Brazil; Takeda Oncology Brazil
Consulting or Advisory Role - AstraZeneca; JANSSEN Oncology BRAZIL; MSD; Novartis; Novartis; Roche Oncology Brazil; Servier Brazil; Takeda Brazil
Speakers' Bureau - AstraZeneca; BMS Brazil; Instituto D'Or de Pesquisa e Ensino; Janssen Oncology Brazil; MSD; Roche Oncology Brazil; Takeda Brazil
Research Funding - AstraZeneca; Janssen Oncology; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Janssen Oncology; Roche
 
Anelisa Coutinho
Employment - AMO DASA
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS Bristol; Daichii; GeneOne Life Science Inc; Ipsen; Libbs; Lilly; Merck Serono; MSD Oncology; Natera; Pfizer; Roche/Genentech; SERVIER
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Daiichi SAYO; Ipsen; Libbs; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche Molecular Diagnostics; Roche/Genentech; SERVIER
Research Funding - Bristol-Myers Squibb (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Libbs; MSD Oncology; Pfizer
 
Angelica Rodrigues
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; GlaxoSmithKline; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; GlaxoSmithKline; MSD; Roche
 
Carlos Ferreira
Employment - Oncoclinicas & Co
Stock and Other Ownership Interests - Oncoclinicas & Co
Consulting or Advisory Role - AstraZeneca; BeiGene
Speakers' Bureau - BeiGene
 
Everardo Saad
Employment - Dendrix Ltd; International Drug Development Institute (IDDI)
Stock and Other Ownership Interests - Dendrix Ltd
Research Funding - Bristol Myers Squibb (Inst)
 
Jose Bines
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Knight Pharmaceuticals; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Roche